Discover the latest AstraZeneca (#AZN) stock analysis! Despite a 3% year-to-date decline, is now the perfect time to invest? Expert insights reveal the potential upside of this pharmaceutical giant. Learn why AstraZeneca might still be a buy, even amidst market fluctuations. Don't miss out on this comprehensive #AZN stock analysis!